Commitment COM-271
Post-approval commitment for TFDA-2024-0071. Category: Post-Approval Study. Priority: low.
Commitment ID
COM-271
Application
Authority
Taiwan Food and Drug Administration
Category
Post-Approval Study
Priority
low
Status
Overdue
Due Date
2025-01-24
Completed At
—
Owner
Marcus Webb
Created
2023-01-28
Description
Provide confirmatory bioequivalence study for 200 mg strength
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.